FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $73,780 | -96.6% | 34,802 | -92.4% | 0.00% | -92.9% |
Q2 2023 | $2,165,500 | -40.9% | 454,937 | -29.3% | 0.01% | -36.4% |
Q1 2023 | $3,665,778 | -36.5% | 643,119 | +12.3% | 0.02% | -35.3% |
Q4 2022 | $5,777,019 | -0.3% | 572,549 | +121.4% | 0.03% | +3.0% |
Q3 2022 | $5,796,000 | -36.3% | 258,626 | -29.5% | 0.03% | -41.1% |
Q2 2022 | $9,096,000 | +1280.3% | 367,062 | +2058.4% | 0.06% | +833.3% |
Q1 2022 | $659,000 | +6.3% | 17,006 | +60.5% | 0.01% | 0.0% |
Q4 2021 | $620,000 | -87.1% | 10,596 | -86.9% | 0.01% | -90.2% |
Q3 2021 | $4,803,000 | +194.5% | 81,034 | +331.1% | 0.06% | +238.9% |
Q2 2021 | $1,631,000 | -54.1% | 18,796 | -56.4% | 0.02% | -60.0% |
Q1 2021 | $3,552,000 | -45.3% | 43,079 | -39.6% | 0.04% | -49.4% |
Q4 2020 | $6,489,000 | +87.8% | 71,360 | -17.5% | 0.09% | +74.5% |
Q3 2020 | $3,456,000 | +115100.0% | 86,472 | +86372.0% | 0.05% | – |
Q2 2020 | $3,000 | -99.7% | 100 | -99.8% | 0.00% | -100.0% |
Q4 2019 | $865,000 | – | 44,217 | +884240.0% | 0.02% | – |
Q3 2019 | $0 | -100.0% | 5 | -99.9% | 0.00% | -100.0% |
Q2 2019 | $100,000 | +100.0% | 4,948 | +72.9% | 0.00% | 0.0% |
Q1 2019 | $50,000 | -81.7% | 2,862 | -86.5% | 0.00% | -84.6% |
Q4 2018 | $273,000 | – | 21,265 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |